Literature DB >> 34040250

Had COVID? You'll probably make antibodies for a lifetime.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  Immunology; Infection; Medical research; SARS-CoV-2

Year:  2021        PMID： 34040250     DOI： 10.1038/d41586-021-01442-9

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Authors:  Quan-Xin Long; Xiao-Jun Tang; Qiu-Lin Shi; Qin Li; Hai-Jun Deng; Jun Yuan; Jie-Li Hu; Wei Xu; Yong Zhang; Fa-Jin Lv; Kun Su; Fan Zhang; Jiang Gong; Bo Wu; Xia-Mao Liu; Jin-Jing Li; Jing-Fu Qiu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-06-18       Impact factor: 53.440

2.  The incidence of rheumatoid vasculitis in the Norwich Health Authority.

Authors:  R A Watts; D M Carruthers; D P Symmons; D G Scott
Journal:  Br J Rheumatol       Date:  1994-09

3.  Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.

Authors:  Naoki Kaneko; Hsiao-Hsuan Kuo; Julie Boucau; Jocelyn R Farmer; Hugues Allard-Chamard; Vinay S Mahajan; Alicja Piechocka-Trocha; Kristina Lefteri; Matthew Osborn; Julia Bals; Yannic C Bartsch; Nathalie Bonheur; Timothy M Caradonna; Josh Chevalier; Fatema Chowdhury; Thomas J Diefenbach; Kevin Einkauf; Jon Fallon; Jared Feldman; Kelsey K Finn; Pilar Garcia-Broncano; Ciputra Adijaya Hartana; Blake M Hauser; Chenyang Jiang; Paulina Kaplonek; Marshall Karpell; Eric C Koscher; Xiaodong Lian; Hang Liu; Jinqing Liu; Ngoc L Ly; Ashlin R Michell; Yelizaveta Rassadkina; Kyra Seiger; Libera Sessa; Sally Shin; Nishant Singh; Weiwei Sun; Xiaoming Sun; Hannah J Ticheli; Michael T Waring; Alex L Zhu; Galit Alter; Jonathan Z Li; Daniel Lingwood; Aaron G Schmidt; Mathias Lichterfeld; Bruce D Walker; Xu G Yu; Robert F Padera; Shiv Pillai
Journal:  Cell       Date:  2020-08-19       Impact factor: 41.582
  3 in total
  2 in total

Review 1.  Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

Authors:  Gaurav Joshi; Pobitra Borah; Shweta Thakur; Praveen Sharma; Ramarao Poduri
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 2.  Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection.

Authors:  Alberto Boretti
Journal:  J Trace Elem Med Biol       Date:  2022-02-17       Impact factor: 3.995
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.